• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » UPDATE: Hologic owes Conceptus $19M in patent fight

UPDATE: Hologic owes Conceptus $19M in patent fight

October 19, 2011 By MassDevice staff

Conceptus
Hologic

UPDATED 10/18/2011 with comment from Hologic

Hologic (NSDQ:HOLX) lost its legal battle with Conceptus (NSDQ:CPTS) over patents covering female sterilization technology.

A California jury awarded Conceptus $18.8 million and royalties of 20 percent after finding that Hologic violated five patents covering the Conceptus Essure system with its competing Adiana system.

Mountain View, Calif.-based Conceptus had sued its Bedford, Mass.-based competitor in May 2009.

Essure uses a flexible coil partly made of copper to permanently block the fallopian tubes. The device is delivered via a trans-cervical catheter. In 2009 Judge William Alsup of the U.S. District Court for Northern California denied a Conceptus motion seeking a preliminary injunction barring Hologic from bringing its Adiana treatment to market. That system, which won 510(k) clearance from the Food & Drug Administration in July 2009, also uses a small insert to occlude the fallopian tubes. But the Adiana procedure first applies radiofrequency energy to small sections of the tube, before a silicone plug is implanted.

“The jury verdict acknowledges the invention Conceptus pioneered more than a decade ago that is the foundation of the Essure procedure. We remain committed to continuously defending our intellectual property while we work to achieve our long-term goal of making Essure the standard of care in permanent birth control,” Conceptus president & CEO Mark Sieczkarek said in prepared remarks.

Hologic said the verdict won’t have any impact on its operations or finances because “the payment, should it be paid, would be deducted from the contingent consideration otherwise due to former Adiana Inc. shareholders (the former owners of the Adiana system).”

“We are obviously disappointed in this verdict. However, there remain several issues to be decided by the court which could impact the ultimate disposition of the case,” Holgic general counsel Mark Caseysaid in prepared remarks. “Upon resolution of those issues, the company will evaluate its options. In the meantime, the company will continue to sell, market and promote the Adiana System.”

Filed Under: Legal News, News Well, Patent Infringement, Women's Health Tagged With: Conceptus Inc., Hologic

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy